Will Kisunla™ be approved by the EMA by end of 2024? | Binary | | | 2 months ago | |
Will Lecanemab be approved by the MHRA by December 31, 2024? | Binary | | | 4 months ago | |
Will Kisunla™ reach $1 billion in global sales by end of 2025? | Binary | | | 2 months ago | |
What will be the reduction in Alzheimer's progression in Kisunla™ studies by end of 2024? | Categorical | | | 2 months ago | |
Will NHS England approve Kisunla™ for Alzheimer's by mid-2025? | Binary | | | 2 months ago | |
What will Kisunla™'s market share be in the UK by end of 2025? | Categorical | | | 2 months ago | |
In how many countries will Kisunla™ be approved by end of 2025? | Categorical | | | 2 months ago | |
What will be the market share of Lecanemab in the UK Alzheimer's treatment market by December 31, 2025? | Categorical | | | 4 months ago | |
Will Lecanemab be prescribed privately in the UK by March 31, 2025? | Binary | | | 4 months ago | |
How many patients will be prescribed Lecanemab in the UK by December 31, 2025? | Categorical | | | 4 months ago | |
What will be the percentage reduction in Alzheimer's progression rate among patients using Lecanemab by December 31, 2025? | Categorical | | | 4 months ago | |
Will Lecanemab be available through the NHS by June 30, 2025? | Binary | | | 4 months ago | |
